Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
ViewAttendees 2

C5C - Deep Learning in PKPD and Pharmacometrics: Diversity of Approaches and Applications

Wednesday, November 13, 2024
1:45 PM – 3:15 PM MST
Location: Sonoran Sky Ballroom 5 - 8

Disclosure(s):
Sean Hayes, PhD: Merck & Co, Inc.: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Omid Bazgir, PhD: No financial relationships to disclose
Louis Joslyn, PhD: Genentech, Inc.: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Presentations:

  • 1:45 PM – 2:15 PM MST
    Protein Language Models to incorporate PKPD considerations in early antibody design and generation

    Speaker: Louis Joslyn, PhD – Preclinical and Translational Pharmacokinetics/Pharmacodynamics, Genentech

  • 2:15 PM – 2:45 PM MST
    Towards Generalizability of Neural ODEs in predictive applications in pharmacometrics

    Speaker: Sean Hayes, PhD – Merck Research Laboratories

  • 2:45 PM – 3:15 PM MST
    Integration of Graph Neural Network and Neural-ODEs for Tumor Dynamic Prediction

    Speaker: Omid Bazgir, PhD (he/him/his) – Genentech Inc.